361 related articles for article (PubMed ID: 30066023)
1. Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1257-1274. PubMed ID: 30066023
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl fumarate protects thioacetamide-induced liver damage in rats: Studies on Nrf2, NLRP3, and NF-κB.
Dwivedi DK; Jena G; Kumar V
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22476. PubMed ID: 32060995
[TBL] [Abstract][Full Text] [Related]
4. Diethylnitrosamine and thioacetamide-induced hepatic damage and early carcinogenesis in rats: Role of Nrf2 activator dimethyl fumarate and NLRP3 inhibitor glibenclamide.
Dwivedi DK; Jena GB
Biochem Biophys Res Commun; 2020 Feb; 522(2):381-387. PubMed ID: 31761320
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Modulation of NLRP3 Inflammasome and Nrf2/ARE Pathway Rescues Thioacetamide-Induced Hepatic Damage in Mice: Role of Oxidative Stress and Inflammation.
Dwivedi DK; Jena GB
Inflammation; 2022 Apr; 45(2):610-626. PubMed ID: 34664134
[TBL] [Abstract][Full Text] [Related]
6. Detrimental effects of nicotine on thioacetamide-induced liver injury in mice.
Zhou Z; Park S; Kim JW; Zhao J; Lee MY; Choi KC; Lim CW; Kim B
Toxicol Mech Methods; 2017 Sep; 27(7):501-510. PubMed ID: 28440100
[TBL] [Abstract][Full Text] [Related]
7. Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation.
Aher JS; Khan S; Jain S; Tikoo K; Jena G
Hum Exp Toxicol; 2015 Jan; 34(1):44-55. PubMed ID: 24812151
[TBL] [Abstract][Full Text] [Related]
8. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation.
Wang X; Fu T; Wang J; Wang C; Liu K; Wu J; Sun H; Ma X; Sun P; Meng Q
Int Immunopharmacol; 2019 Oct; 75():105833. PubMed ID: 31450152
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin as a therapeutic agent for attenuating hepatic stellate cell activation in thioacetamide-induced liver fibrosis.
Pu TY; Chuang KC; Tung MC; Yen CC; Chen YH; Cidem A; Ko CH; Chen W; Chen CM
Biomed Pharmacother; 2024 May; 174():116490. PubMed ID: 38554526
[TBL] [Abstract][Full Text] [Related]
10.
Yang HY; Kim KS; Lee YH; Park JH; Kim JH; Lee SY; Kim YM; Kim IS; Kacew S; Lee BM; Kwak JH; Yoon K; Kim HS
Int J Biol Sci; 2019; 15(4):800-811. PubMed ID: 30906211
[TBL] [Abstract][Full Text] [Related]
11. Hepatoprotective effects of naturally fermented noni juice against thioacetamide-induced liver fibrosis in rats.
Lin YL; Lin HW; Chen YC; Yang DJ; Li CC; Chang YY
J Chin Med Assoc; 2017 Apr; 80(4):212-221. PubMed ID: 28268174
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the protective and therapeutic effect of melatonin against thioacetamide-induced acute liver damage.
Sayan M; Karabulut D; Özdamar S
J Biochem Mol Toxicol; 2020 Apr; 34(4):e22450. PubMed ID: 31967703
[TBL] [Abstract][Full Text] [Related]
13. Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis.
Chen IS; Chen YC; Chou CH; Chuang RF; Sheen LY; Chiu CH
J Sci Food Agric; 2012 May; 92(7):1441-7. PubMed ID: 22102319
[TBL] [Abstract][Full Text] [Related]
14. Combination of pomegranate extract and curcumin ameliorates thioacetamide-induced liver fibrosis in rats: impact on TGF-β/Smad3 and NF-κB signaling pathways.
Gowifel AMH; Khalil MG; Nada SA; Kenawy SA; Ahmed KA; Salama MM; Safar MM
Toxicol Mech Methods; 2020 Oct; 30(8):620-633. PubMed ID: 32718261
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of Tinospora cordifolia miers extract against hepatic and neurobehavioral deficits in thioacetamide-induced hepatic encephalopathy in rats via modulating hyperammonemia and glial cell activation.
Ali SA; Datusalia AK
J Ethnopharmacol; 2024 Apr; 323():117700. PubMed ID: 38176666
[TBL] [Abstract][Full Text] [Related]
16. Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3/HMGB1/TLR4 signaling pathway.
Yao Y; Zuo X; Shao F; Yu K; Liang Q
Phytomedicine; 2024 Jun; 128():155502. PubMed ID: 38489889
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of Moringa oleifera leaves ethanolic extract against thioacetamide-induced hepatotoxicity in rats via modulation of cellular antioxidant, apoptotic and inflammatory markers.
Mousa AA; El-Gansh HAI; Eldaim MAA; Mohamed MAE; Morsi AH; El Sabagh HS
Environ Sci Pollut Res Int; 2019 Nov; 26(31):32488-32504. PubMed ID: 31617137
[TBL] [Abstract][Full Text] [Related]
18. Caffeine intake decreases oxidative stress and inflammatory biomarkers in experimental liver diseases induced by thioacetamide: Biochemical and histological study.
Amer MG; Mazen NF; Mohamed AM
Int J Immunopathol Pharmacol; 2017 Mar; 30(1):13-24. PubMed ID: 28281876
[TBL] [Abstract][Full Text] [Related]
19. Dimethyl fumarate-mediated Nrf2/ARE pathway activation and glibenclamide-mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes-associated fatty liver in rats by mitigating oxidative stress and inflammation.
Dwivedi DK; Jena GB
J Biochem Mol Toxicol; 2023 Jul; 37(7):e23357. PubMed ID: 36999408
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice.
El-Kashef DH; Serrya MS
Life Sci; 2019 Jul; 228():266-273. PubMed ID: 31077717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
